GHK-Cu (glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring copper-binding tripeptide first isolated from human plasma by Loren Pickart in 1973. The peptide consists of three amino acids โ glycine, histidine, and lysine โ that form a high-affinity complex with copper(II) ions. Found naturally in human plasma, saliva, and urine, GHK-Cu levels decline with age, from approximately 200 ng/mL in plasma at age 20 to approximately 80 ng/mL by age 60 (Pickart L et al., 2012; PMID 22666519)1.
GHK-Cu has attracted research interest for its diverse biological activities, including wound healing, extracellular matrix remodeling, antioxidant defense, anti-inflammatory signaling, and modulation of gene expression patterns associated with tissue repair and regeneration.
GHK-Cu exerts its biological effects through multiple interconnected mechanisms:
The copper(II) ion is essential for the activity of numerous metalloenzymes involved in tissue repair, including lysyl oxidase (collagen cross-linking), superoxide dismutase (antioxidant defense), and cytochrome c oxidase (mitochondrial respiration).
- Collagen synthesis: Stimulates production of collagen types I, III, and V (Pickart L et al., 2018)2
- Glycosaminoglycans: Increases decorin, heparan sulfate, and chondroitin sulfate synthesis2
- Matrix metalloproteinases: Modulates MMP activity to balance tissue degradation and rebuilding2
Broad Connectivity Map (CMAP) analyses report GHK-Cu may modulate the expression of approximately 31.2% of human genes (~4,000+ genes), with upregulation of genes associated with tissue repair and stem cell function, and downregulation of genes associated with inflammation and tissue destruction (Pickart L et al., 2015; PMID 26236730)3.
Research on GHK-Cu spans dermatology, wound healing, and regenerative medicine. Animal studies have reported accelerated wound closure, increased collagen deposition, and anti-inflammatory effects2. In cosmetic applications, clinical studies have reported improvements in skin firmness, elasticity, and appearance of fine lines (magnitude varies across small clinical studies).
- Primarily studied in preclinical models; limited controlled human clinical trial data
- Widely available in cosmetic formulations (topical creams and serums)
- Copper toxicity is a theoretical concern at high systemic doses
- Not FDA-approved as a therapeutic agent
GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration, published in BioMed Research International (Pickart L et al., 2015; PMID: 26236730):
- The study showed GHK modulates expression of 31.2% of human genes